# Lateralization of FDG-PET Hypometabolism Using Resting-State fMRI in Temporal Lobe Epilepsy: A Simultaneous PET-MRI Study

**Authors:** Daniel Uher, Gerhard S. Drenthen, Tineke van de Weijer, Jochem van der Pol, Christianne M. Hoeberigs, Paul A. M. Hofman, Sam Springer, Rob P. W. Rouhl, Albert J. Colon, Olaf E. M. G. Schijns, Walter H. Backes, Jacobus F. A. Jansen

PMC · DOI: 10.3390/tomography12030030 · Tomography · 2026-03-02

## TL;DR

This study explores whether resting-state fMRI can identify brain regions with reduced metabolism in epilepsy patients, using PET scans as a reference.

## Contribution

The study demonstrates that fALFF from resting-state fMRI correlates with FDG-PET hypometabolism in temporal lobe epilepsy.

## Key findings

- fALFF asymmetry indices were significantly reduced in hypometabolic zones identified by FDG-PET.
- A significant negative correlation was found between FDG-PET and slow-3 band fALFF (r = −0.62, p < 0.05).
- Conventional and slow-3 band fALFF may replicate FDG-PET findings for epileptogenic zone localization.

## Abstract

This study investigated whether resting-state fMRI (rs-fMRI) can localize the epileptogenic onset zone in temporal lobe epilepsy (TLE) using FDG-PET as ground truth. Twelve patients with drug-resistant TLE underwent simultaneous PET-MR scanning at 3T. Hypometabolic regions identified on FDG-PET were compared with rs-fMRI metrics including regional homogeneity (ReHo), amplitude of low-frequency fluctuations (ALFF), and fractional ALFF (fALFF) calculated in conventional and slow-3 frequency bands. Results showed that fALFF asymmetry indices were significantly reduced in hypometabolic zones, with a significant negative correlation between FDG-PET and slow-3 fALFF (r = −0.62, p < 0.05). These findings suggest fALFF may replicate FDG-PET findings for epileptogenic zone localization.

Background: In temporal lobe epilepsy (TLE), locally reduced glucose metabolism (i.e., hypometabolism) is indicative of the epileptogenic onset zone (EZ). Here, we investigate the potential value of resting-state fMRI (rs-fMRI) for localizing the EZ with fluorodeoxyglucose positron emission tomography (FDG-PET) as ground truth. Methods: Twelve PET-positive patients (34.1 ± 13.1 y; 5 females) with unilateral drug-resistant TLE were included. FDG-PET and rs-fMRI were acquired simultaneously at a hybrid 3T PET-MR scanner. Hypometabolic regions were identified on the FDG-PET images by a nuclear medicine expert. The FDG-PET images were compared with a clinical FDG-PET control dataset with normal glucose uptake distribution. The output z-score maps were thresholded at z < −2 to produce a binary mask of the significantly hypometabolic regions. The hypometabolism masks were mirrored onto the contralateral hemisphere for the asymmetry comparison. Regional homogeneity (ReHo), amplitude of low-frequency fluctuations (ALFF), and fractional ALFF (fALFF) were calculated from the rs-fMRI in conventional (0.01–0.1 Hz) and slow-3 (0.073–0.198 Hz) frequency bands. Asymmetry indices (AIs) were calculated using the ipsilateral and contralateral hypometabolic masks in the PET-positive subjects and assessed via the one-sample Wilcoxon test and Spearman correlation coefficients. Results: The AIs of conventional fALFF were significantly lower in the hypometabolic zone (p < 0.05). A significant negative correlation was found between the AIs of FDG-PET and fALFF in the slow-3 band (r = −0.62; p < 0.05). Conclusions: Conventional and slow-3 band fALFF showed a potential to mimic the FDG-PET findings in terms of EZ localization. Further research with extended cohorts and histopathological validation is required to determine the clinical value.

## Linked entities

- **Diseases:** temporal lobe epilepsy (MONDO:0005115)

## Full-text entities

- **Diseases:** glucose hypometabolism (MESH:D018149), reduced (MESH:D001523), Epilepsy (MESH:D004827), mesial temporal lobe epilepsy (MESH:C566903), DRE (MESH:D000069279), hippocampal sclerosis (MESH:D000092223), injury to (MESH:D014947), epileptiform activity (MESH:D014277), neuronal loss (MESH:D009410), complex partial seizure (MESH:D012640), lobe (MESH:D008878), HS (MESH:C567159), epileptic abnormalities (MESH:D025063), absence epilepsy (MESH:D004832), epileptic condition (MESH:D020763), TLE (MESH:D004833)
- **Chemicals:** 18F-FDG (MESH:D019788), oxygen (MESH:D010100), ASM (-), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029870/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029870/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029870/full.md

---
Source: https://tomesphere.com/paper/PMC13029870